|
Iridex was notified of a patient experiencing macular edema during a procedure using micropulse p3 probe (mp3 probe).The condition caused temporary visual disturbance but resolved without additional treatment.The doctor indicated it was likely a known complication of the procedure, not a device malfunction.Device was not returned to iridex for further investigation.Iridex takes proactive approach in notifying fda regarding any adverse events and hence a medwatch (3500a) form is being submitted for this adverse event.
|